FDAQRC Celebrates 17 Years of Growth, Global Expertise and Innovation
October 2026 — FDA Quality and Regulatory Consultants (FDAQRC), a global provider of quality and regulatory compliance consulting services, is celebrating 17 years in business. Since its founding in 2009, FDAQRC has grown into a global resource for life sciences organizations, supported by a network of more than 500 consultants across over 70 countries.
This year reflects continued growth and a commitment to evolving alongside the industry. With the recent acquisition of Compliance Architects, an expanding team and new technology initiatives on the horizon, FDAQRC is building on its established expertise while preparing to meet emerging client needs.
One of the most significant developments in FDAQRC’s 17th year was the acquisition of Compliance Architects, completed July 2026. The addition brings complementary expertise and proprietary solutions into the FDAQRC portfolio, broadening the support available to life sciences organizations.
FDAQRC has traditionally focused on clinical and laboratory compliance, while Compliance Architects brings extensive experience in GMP compliance, quality systems, commercial operations, inspection preparedness and complex enforcement response.
Together, the organizations can support a broader range of needs, from early clinical development and laboratory operations through manufacturing, commercialization and post-market compliance. This expanded portfolio gives clients access to a wider range of expertise and resources through one consulting partner.
The acquisition also introduces three proprietary Compliance Architects solutions to FDAQRC’s offerings:
- Writing for Compliance® — A training program designed to strengthen documentation practices and help quality and operations teams prepare for regulatory inspections.
- Quality Pulse® — A quality culture assessment approach that uses behavioral insights and data analytics to help organizations identify opportunities for improvement.
- CRPN Quality Roadmap® — A structured, risk-based planning framework that helps life sciences manufacturers prioritize compliance risks and allocate resources effectively.
As technology continues to shape the life sciences industry, FDAQRC is preparing to introduce new AI-powered compliance capabilities in late 2026. The upcoming initiative will focus on helping organizations find, understand and act on critical quality and compliance information within a secure, governed environment.
Exploring through AI-driven innovation, FDAQRC’s upcoming capabilities will bring together AI-powered search, document intelligence and regulatory insights to make complex information more accessible and actionable. By combining emerging technology with FDAQRC’s established regulatory and quality expertise, the initiative aims to help life sciences organizations navigate compliance challenges, access critical information and make more informed decisions.
FDAQRC continued to grow its internal team in 2026. FDAQRC team members remain active in the industry through participation in conferences and professional events, including Society of Quality Assurance (SQA) events, the Global QA Conference hosted by the Research Quality Association (RQA), MD&M Midwest by Informa, and the 2026 Enforcement, Litigation, and Compliance Conference hosted by the Food and Drug Law Institute (FDLI). These events provide opportunities to connect with industry professionals, exchange insights and stay informed on evolving quality and regulatory priorities as FDAQRC looks ahead to 2027.
With the addition of Compliance Architects and AI-powered compliance capabilities on the horizon, FDAQRC continues to expand its services to meet the evolving needs of the life sciences industry. Seventeen years after its founding, the company remains focused on helping organizations strengthen quality systems, prepare for regulatory scrutiny and navigate compliance challenges with confidence.
From preclinical to commercial, FDAQRC remains committed to helping life sciences organizations navigate regulatory challenges with experienced professionals and comprehensive compliance solutions.
With expanded expertise spanning clinical, laboratory, manufacturing and commercial compliance, FDAQRC is equipped to support life sciences organizations at every stage of development. Explore all our life science services here or drop us a message below.
